Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Histone demethylase JMJD1C regulates esophageal cancer proliferation Via YAP1 signaling.

Cai Y, Fu X, Deng Y.

Am J Cancer Res. 2017 Jan 1;7(1):115-124. eCollection 2017.

2.

Hepatitis B virus X protein mediates yes-associated protein 1 upregulation in hepatocellular carcinoma.

Wu Y, Zhang J, Zhang H, Zhai Y.

Oncol Lett. 2016 Sep;12(3):1971-1974. Epub 2016 Jul 20.

3.

Effect of YAP1 silencing on esophageal cancer.

Zhao J, Li X, Yang Y, Zhu D, Zhang C, Liu D, Wu K, Zhao S.

Onco Targets Ther. 2016 May 26;9:3137-46. doi: 10.2147/OTT.S102338. eCollection 2016.

4.

New insights into posttranslational modifications of Hippo pathway in carcinogenesis and therapeutics.

He M, Zhou Z, Shah AA, Hong Y, Chen Q, Wan Y.

Cell Div. 2016 Mar 31;11:4. doi: 10.1186/s13008-016-0013-6. eCollection 2016. Review.

5.

Nuclear translocation and activation of YAP by hypoxia contributes to the chemoresistance of SN38 in hepatocellular carcinoma cells.

Dai XY, Zhuang LH, Wang DD, Zhou TY, Chang LL, Gai RH, Zhu DF, Yang B, Zhu H, He QJ.

Oncotarget. 2016 Feb 9;7(6):6933-47. doi: 10.18632/oncotarget.6903.

6.

A YAP/TAZ-miR-130/301 molecular circuit exerts systems-level control of fibrosis in a network of human diseases and physiologic conditions.

Bertero T, Cottrill KA, Annis S, Bhat B, Gochuico BR, Osorio JC, Rosas I, Haley KJ, Corey KE, Chung RT, Nelson Chau B, Chan SY.

Sci Rep. 2015 Dec 15;5:18277. doi: 10.1038/srep18277.

7.

The tumor suppressor HHEX inhibits axon growth when prematurely expressed in developing central nervous system neurons.

Simpson MT, Venkatesh I, Callif BL, Thiel LK, Coley DM, Winsor KN, Wang Z, Kramer AA, Lerch JK, Blackmore MG.

Mol Cell Neurosci. 2015 Sep;68:272-83. doi: 10.1016/j.mcn.2015.08.008. Epub 2015 Aug 23.

8.

YAP is a critical oncogene in human cholangiocarcinoma.

Pei T, Li Y, Wang J, Wang H, Liang Y, Shi H, Sun B, Yin D, Sun J, Song R, Pan S, Sun Y, Jiang H, Zheng T, Liu L.

Oncotarget. 2015 Jul 10;6(19):17206-20.

9.

A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ.

Tan G, Cao X, Dai Q, Zhang B, Huang J, Xiong S, Zhang Yy, Chen W, Yang J, Li H.

Oncotarget. 2015 Apr 20;6(11):8676-86.

10.

Structure-Based Design and Synthesis of Potent Cyclic Peptides Inhibiting the YAP-TEAD Protein-Protein Interaction.

Zhang Z, Lin Z, Zhou Z, Shen HC, Yan SF, Mayweg AV, Xu Z, Qin N, Wong JC, Zhang Z, Rong Y, Fry DC, Hu T.

ACS Med Chem Lett. 2014 Jul 14;5(9):993-8. doi: 10.1021/ml500160m. eCollection 2014 Sep 11.

11.

Hypoxic conditions differentially regulate TAZ and YAP in cancer cells.

Yan L, Cai Q, Xu Y.

Arch Biochem Biophys. 2014 Nov 15;562:31-6. doi: 10.1016/j.abb.2014.07.024. Epub 2014 Jul 29.

12.

Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma.

Tu K, Yang W, Li C, Zheng X, Lu Z, Guo C, Yao Y, Liu Q.

Mol Cancer. 2014 May 17;13:110. doi: 10.1186/1476-4598-13-110.

13.

The use of Yes-associated protein expression in the diagnosis of persistent neonatal cholestatic liver disease.

Gurda GT, Zhu Q, Bai H, Pan D, Schwarz KB, Anders RA.

Hum Pathol. 2014 May;45(5):1057-64. doi: 10.1016/j.humpath.2014.01.002. Epub 2014 Jan 23.

14.

The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment.

Johnson R, Halder G.

Nat Rev Drug Discov. 2014 Jan;13(1):63-79. doi: 10.1038/nrd4161. Epub 2013 Dec 13. Review.

15.

Functional role of Mst1/Mst2 in embryonic stem cell differentiation.

Li P, Chen Y, Mak KK, Wong CK, Wang CC, Yuan P.

PLoS One. 2013 Nov 5;8(11):e79867. doi: 10.1371/journal.pone.0079867. eCollection 2013.

16.

Increased expression of Yes-associated protein 1 in hepatocellular carcinoma with stemness and combined hepatocellular-cholangiocarcinoma.

Kim GJ, Kim H, Park YN.

PLoS One. 2013 Sep 24;8(9):e75449. doi: 10.1371/journal.pone.0075449. eCollection 2013.

17.

RAF kinase inhibitor-independent constitutive activation of Yes-associated protein 1 promotes tumor progression in thyroid cancer.

Lee SE, Lee JU, Lee MH, Ryu MJ, Kim SJ, Kim YK, Choi MJ, Kim KS, Kim JM, Kim JW, Koh YW, Lim DS, Jo YS, Shong M.

Oncogenesis. 2013 Jul 15;2:e55. doi: 10.1038/oncsis.2013.12.

18.

Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1.

Yang L, Inokuchi S, Roh YS, Song J, Loomba R, Park EJ, Seki E.

Gastroenterology. 2013 May;144(5):1042-1054.e4. doi: 10.1053/j.gastro.2013.01.056. Epub 2013 Feb 4.

19.

PTPN14 is required for the density-dependent control of YAP1.

Wang W, Huang J, Wang X, Yuan J, Li X, Feng L, Park JI, Chen J.

Genes Dev. 2012 Sep 1;26(17):1959-71. doi: 10.1101/gad.192955.112.

20.

Down-regulation of Yes Associated Protein 1 expression reduces cell proliferation and clonogenicity of pancreatic cancer cells.

Diep CH, Zucker KM, Hostetter G, Watanabe A, Hu C, Munoz RM, Von Hoff DD, Han H.

PLoS One. 2012;7(3):e32783. doi: 10.1371/journal.pone.0032783. Epub 2012 Mar 1.

Supplemental Content

Support Center